CDNA
CareDx, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$53.83
−0.83%Forward multiples
Based on analyst estimates
- P/E forward
- 48.57x
- P/E 2026E
- 45.08x
- P/E 2027E
- 40.86x
- P/E 2028E
- 29.49x
- P/S forward
- 5.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.02x
- PEG TTM
- —
- Price / book
- 6.54x
- Price / sales
- 6.08x
- Price / cash flow
- 29.73x
Enterprise value
- Enterprise value
- $2.4B
- EV / sales
- 5.31x
- EV / EBITDA
- 156.22x
- EV / EBIT
- -574.44x
- Market cap
- $2.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026